|
CDCA7L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.44089209850063E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.95519997361993E-09 |
| Normal-vs-Stage2 |
3.265800E-02 |
| Normal-vs-Stage3 |
1.138160E-02 |
| Normal-vs-Stage4 |
8.438300E-02 |
| Stage1-vs-Stage2 |
3.160000E-02 |
| Stage1-vs-Stage3 |
9.837500E-03 |
| Stage1-vs-Stage4 |
5.025400E-01 |
| Stage2-vs-Stage3 |
9.222200E-01 |
| Stage2-vs-Stage4 |
6.305600E-01 |
| Stage3-vs-Stage4 |
5.391400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.97208915864167E-12 |
| Normal-vs-AfricanAmerican |
5.53979999999843E-05 |
| Normal-vs-Asian |
9.162400E-01 |
| Caucasian-vs-AfricanAmerican |
2.102000E-01 |
| Caucasian-vs-Asian |
1.149960E-02 |
| AfricanAmerican-vs-Asian |
1.833960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.72795152922845E-14 |
| Normal-vs-Female |
2.4962999999989E-05 |
| Male-vs-Female |
9.522200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.190400E-04 |
| Normal-vs-Extreme_Weight |
2.23529999954231E-07 |
| Normal-vs-Obese |
2.82579999999477E-06 |
| Normal-vs-Extreme_Obese |
7.229200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.058400E-01 |
| Normal_Weight-vs-Obese |
5.417600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.263800E-03 |
| Extreme_Weight-vs-Obese |
8.957200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.096760E-03 |
| Obese-vs-Extreme_Obese |
1.102630E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.164170E-01 |
| Normal-vs-Age(41-60Yrs) |
4.15850021084907E-10 |
| Normal-vs-Age(61-80Yrs) |
5.25660004413453E-09 |
| Normal-vs-Age(81-100Yrs) |
9.562000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.195600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.881800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.551600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.874500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.278600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.649200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63924429585904E-12 |
| Normal-VS-Type2 PRCC |
2.447600E-04 |
| Normal-VS-KIRP CIMP |
1.54217999999151E-05 |
| Normal-VS-Unclassified PRCC |
5.859600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.432110E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.62436730732907E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
4.712400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.67970004572027E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
1.865810E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.975200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.955800E-03 |
| Normal-vs-N1 |
3.182100E-02 |
| Normal-vs-N2 |
6.761800E-01 |
| N0-vs-N1 |
9.866200E-01 |
| N0-vs-N2 |
5.658800E-01 |
| N1-vs-N2 |
5.396600E-01 |
|
|
